Fresenius Granuflo Recall Lawsuit News

Naturalyte GranuFlo Acid Concentrate and Liquid Acid Concentrate, products of the German company Fresenius Medical Care, have been linked to an increased risk of heart attack. Granuflo recall lawsuits gained ground when the FDA announced the company was suspected of withholding information regarding the risk if Fresenius Granfulo heart attacks. Granuflo products are dialysates, and are used in tandem with dialysis machines to rid the blood of contaminants and decrease acidity. The Granuflo heart attack recall was issued in response to finding that the drug increases bicarbonate levels in the blood, increasing the risk of heart attack six fold. Dialysis patients may have been exposed to Granuflo products in clinics operated by Fresenius (the company is the nation's largest holder of dialysis clinics) and those operated by other entities. The greatly increased risk of heart attack associated with Fresenius Granuflo products has led to a surge of Granuflo recall lawsuits. If you or a family member suffered a heart attack after using Granuflo, read here for more information on Granuflo recall lawsuits and the services of Fresenius Granflo recall attorneys.